B2M and prostate carcinoma: Overexpression of β2-M in human prostate cancer cell lines leads to inhibition of tumor growth in vivo and using the β2-M Ab to interrupt β2-M signaling in human prostate cancer cell lines inhibits cancer cell growth and induces cell apoptosis (13).